Records containing: Myeloma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-12-14Imageguided Theranostics in Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2022-09-06Safety and Efficacy Study of Chimeric Antigen Receptor T (CAR-T) Cells in the Treatment of Relapsed/Refractory Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2022-05-03Assessment of the Proportion of Patients With Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy.
-
CLINICAL_TRIALS study record update · 2022-04-29Dual-Energy Computed Tomography for Improving Imaging Assessment of Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2022-01-24Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignancies (THERMAL)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-01-11Development of a Machine Learning Support for Reading Whole Body Diffusion Weighted Magnetic Resonance Imaging (WB-DW-MRI) in Myeloma for the Detection and Quantification of the Extent of Disease Before and After Treatment
-
CLINICAL_TRIALS study record update · 2021-11-24A Phase II Randomized Study of the Efficacy of Minocycline vs. Placebo to Reduce Symptom Burden During Maintenance Therapy for Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2021-10-08Feasibility of an Adapted Physical Activity Program for Patients Treated With an Autologous Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2021-08-09MRI in Multiple Myeloma: Analysis of the Axial Skeleton Versus Whole Body. What is the Required Analysis?
-
CLINICAL_TRIALS study record update · 2021-04-01Pharmacogenomic Study to Predict Survival, Best Response and Toxicity in Newly Diagnosed Myeloma Patients Above the Age of 65 Treated With Either a Combination of Melphalan-prednisone-thalidomide or Lenalidomide-dexamethasone
-
CLINICAL_TRIALS study record update · 2020-10-08Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors
-
CLINICAL_TRIALS study record update · 2020-08-12IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2020-06-09Insuffisance Cardiaque Sous Carfilzomib: étude Prospective
-
CLINICAL_TRIALS study record update · 2020-05-05High-dose Gemcitabine, Busulfan and Melphalan With Autologous Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma
-
CLINICAL_TRIALS study record update · 2020-04-27ClinicalTrials.gov study NCT01916135
-
CLINICAL_TRIALS study record update · 2020-04-21A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2020-04-16Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation
-
CLINICAL_TRIALS study record update · 2020-04-01African American Cancer Clinical Trial Decisions: Testing Tailored Messages
-
CLINICAL_TRIALS study record update · 2020-03-19Phase II Combination Immunotherapy After ASCT for Advanced Myeloma to Study MAGE-A3 Immunizations With Hiltonol® (Poly-ICLC) Plus Transfer of Vaccine-Primed Autologous T Cells Followed by Lenalidomide Maintenance
-
CLINICAL_TRIALS study record update · 2019-12-16Spanish Translation and Linguistic Validation of the Patient- Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
-
CLINICAL_TRIALS study record update · 2019-11-19Place of the Hevylite Test in the Evaluation of MRD in Myeloma
-
CLINICAL_TRIALS study record update · 2019-11-15A Phase I Ascending Dose and Exploratory Expansion Study of DS-3032b, an Oral MDM2 Inhibitor, in Subjects With Relapsed and/or Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2019-10-25Phase I Study of Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2019-07-16A Phase 1/2 Trial Evaluating Treatment of Emergent Graft Versus Host Disease (GvHD) With AP1903 After Planned Donor Infusions (DLIs) of T-cells Genetically Modified With the iCasp9 Suicide Gene in Patients With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2019-06-26Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma. A Multicenter Phase II Trial